Performance of two-stage continual reassessment method relative to an optimal benchmark

Clinical Trials

Volumn 10, Issue 6, 2013, Pages 862-875

  Wages, Nolan A ^a   Conaway, Mark R ^a   O'Quigley, John ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTINUAL REASSESSMENT METHOD; DOSE CALCULATION; MATHEMATICAL COMPUTING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; THEORETICAL STUDY;

CLINICAL TRIALS, PHASE I AS TOPIC; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIKELIHOOD FUNCTIONS; MAXIMUM TOLERATED DOSE; PROBABILITY; RESEARCH DESIGN; SAMPLE SIZE; STATISTICS AS TOPIC;

EID: 84889828258     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513503521     Document Type: Article

References (13)

1. O'Quigley J, Paoletti X, Maccario J. Non-parametric optimal design in dose finding studies. Biostatistics. 2002 ; 3 (1). 51-56
2. O'Quigley J, Pepe M, Fisher L. Continual reassessment method: A practical design for Phase 1 clinical trials in cancer. Biometrics. 1990 ; 46: 33-48
3. Storer BE. Design and analysis of phase 1 clinical trials. Biometrics. 1989 ; 45: 925-37
4. O'Quigley J, Shen L. Continual reassessment method: A likelihood approach. Biometrics. 1996 ; 52: 673-84
5. Paoletti X, O'Quigley J, Maccario J. Design efficiency in dose finding studies. Comput Stat Data Anal. 2004 ; 45 (2). 197-214
6. Iasonos A, Wilton A, Riedel E, Seshan V, Spriggs D. A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase 1 dose-finding studies. Clin Trials. 2008 ; 5 (5). 465-77
7. Cheung YK Dose-Finding by the Continual Reassessment Method. 1 st edn). Chapman & Hall, Boca Raton, FL, 2011. Boca Raton, FL: Chapman & Hall ; 2011:
8. Shen L, O'Quigley J. Consistency of continual reassessment method under model misspecification. Biometrika. 1996 ; 83: 395-405
9. Lee SM, Cheung YK. Model calibration in the continual reassessment method. Clin Trials. 2009 ; 6 (3). 227-38
10. Paoletti X, Kramar A. A comparison of model choices for the continual reassessment method in phase 1 cancer trials. Stat Med. 2009 ; 28: 3012-28
11. Chevret S. The continual reassessment method in cancer phase 1 clinical trials: A simulation study. Stat Med. 1993 ; 12: 1093-108
12. Daimon S, Zohar S, O'Quigley J. Posterior maximization and averaging for Bayesian working model choice in the continual reassessment method. Stat Med. 2011 ; 30 (13). 1563-73
13. O'Quigley J, Zohar S. Retrospective robustness of the continual reassessment method. J Biopharm Stat. 2010 ; 20 (5). 1013-25